Skip to main content
Clinical Trials/ISRCTN91163727
ISRCTN91163727
Completed
N/A

Developing and evaluating an education programme aimed at increasing physical activity in individuals with diagnosed coronary heart disease: a randomised controlled trial

niversity of Leicester0 sites291 target enrollmentFebruary 27, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Leicester
Enrollment
291
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30286797 results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33637567/ results (added 01/03/2021)

Registry
who.int
Start Date
February 27, 2017
End Date
January 2, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Leicester

Eligibility Criteria

Inclusion Criteria

  • Current participant inclusion criteria as of 13/02/2019:
  • 1\. Aged 18 years or older
  • 2\. 12\-48 months post confirmed diagnosis of a cardiac event (myocardial infarction, angina or acute coronary syndrome)
  • 3\. Able to speak and read English to participate effectively in a group education programme
  • 4\. Willing and able to attend the education sessions and clinic visits
  • 5\. Willing and able to give informed consent
  • 6\. Access to a mobile phone in order to receive text messages
  • 7\. Willingness to allow GP notification of their participation in study and access to patient records for purpose of study
  • 8\. Able to take part in moderate physical activity as assessed using Incremental Shuttle Walk Test (ISWT) (Level three or above)
  • Previous participant inclusion criteria:

Exclusion Criteria

  • 1\. Individuals with a diagnosis of heart failure where the underlying primary cause is not myocardial disease as a result of atherosclerosis will be excluded from this study
  • 2\. Musculoskeletal limitations that would limit physical activity (e.g. musculoskeletal injury)
  • 3\. Participation in another clinical intervention study in the past 12 weeks
  • 4\. Lacks capacity to give informed consent
  • 5\. Severe life\-threatening co\-morbidity (e.g. malignancy)
  • 6\. Poor exercise capacity, (\< level three on the ISWT \[120 metres]), these individuals will be directed back into cardiac rehabilitation (good practice)
  • 7\. Housebound or immobile
  • 8\. Unstable symptoms (chest pain or breathlessness at rest; unstable stage II hypertension \[160/100mmHg], not on necessary medications)
  • 9\. Individuals with no or limited understanding of written or verbal English

Outcomes

Primary Outcomes

Not specified

Similar Trials